BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider

Icon Group is Australia's largest vertically integrated cancer care provider, offering radiation oncology, medical oncology, compounding an...

November 19, 2021 | News

$5M Boost to Innovation in Australia with New Illumina Genomics Lab

Illumina, Inc. (NASDAQ: ILMN), the global leader in genomics, today announced the opening of a new, fully equipped laboratory to help Australian researcher...

November 15, 2021 | News

Research into gut microbiome-autism link reveals new perspective in collaborative Austism CRC study

In the largest study in the field to date, researchers analysed stool samples using Microba's metagenomic analysis, alongside other clinical and biological...

November 12, 2021 | News

Life sciences’ highest achievers awarded with prestigious Industry Excellence Awards

Australian Company of the Year: SpeeDx Australian Emerging Company of the Year: oNKo-innate • Industry Leadership Award: David B...

November 01, 2021 | News

Final ‘foundation stones’ set for future of Australian regenerative medicine

Benchmarking the investment in the sector in Australia in 2019 and 2020, Australia’s Regenerative Medicine Investments Database reveals the ext...

November 01, 2021 | News

Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia

-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia --...

November 01, 2021 | News

Australia’s premier life sciences conferences celebrate and champion the sector

Australia’s biggest week in biotech features the events of the year that the sector has known and trusted for over 35 years, and attracts indus...

October 25, 2021 | News

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

The Australian grant represents PMC-309's third global patent approval since it received grants from Russia in June 2021 and South...

October 20, 2021 | News

Medtronic launched APAC Innovation Challenge in Australia

Medtronic plc (NYSE: MDT), the global leader in healthcare technology, invites Australian businesses to participate in the newly launched Medtronic AP...

October 19, 2021 | News

MYND to Participate in a Monash University (Australia) Proposal for $3 Million Clinical Trial

MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND) (OTC: MYNDF) is pleased to announce that the Company's pr...

October 18, 2021 | News

BioAgilytix Closes Acquisition of Australia-based 360biolabs®

360biolabs®, the most comprehensive contract research organization in Australia and New Zealand, has now officially joined forces with BioAgilytix Labs...

October 14, 2021 | News

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment pro...

October 14, 2021 | News

Medtronic to invest up to US$50m to advance the future of healthcare technologies in APAC

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the launch of the Medtronic Open Innovation Platform (OIP) ...

October 14, 2021 | News

Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announce...

October 08, 2021 | News

Stay Connected